Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma

• Repurposing licensed viral vaccines as anti-cancer therapeutics: Turning cold tumors hot

  2026 Human Vaccines & Immunotherapeutics article Biochemistry, Genetics and Molecular Biology Virus-based gene therapy research Open access

  0

  citations
• Oncolytic virotherapy: Sparking durable anti-tumor immunity through microenvironment modulation

  2025 Seminars in Immunology article Biochemistry, Genetics and Molecular Biology Virus-based gene therapy research Open access

  6

  citations
• BRAF/MEK inhibitor rechallenge in advanced melanoma patients

  2024 Cancer article Biochemistry, Genetics and Molecular Biology Melanoma and MAPK Pathways Open access

  16

  citations
• Therapeutic angiogenesis for patients with chronic limb-threatening ischemia: promising or hoax?

  2024 Vascular Biology article Medicine Peripheral Artery Disease Management Open access

  8

  citations
• Precision cancer medicine: Concepts, current practice, and future developments

  2023 Journal of Internal Medicine article Biochemistry, Genetics and Molecular Biology Cancer Genomics and Diagnostics Open access

  79

  citations
• Preexisting immunity: Barrier or bridge to effective oncolytic virus therapy?

  2023 Cytokine & Growth Factor Reviews review Biochemistry, Genetics and Molecular Biology Virus-based gene therapy research Open access

  52

  citations
• Neoadjuvant Immune Checkpoint Inhibitor Therapy in Melanoma: Efficacy, Safety and Timing

  2022 BioDrugs article Medicine Cancer Immunotherapy and Biomarkers Open access

  6

  citations
• Synthetic biology: at the crossroads of genetic engineering and human therapeutics—a Keystone Symposia report

  2021 Annals of the New York Academy of Sciences article Biochemistry, Genetics and Molecular Biology CRISPR and Genetic Engineering Open access

  10

  citations
• Therapeutic cancer vaccines

  2021 Nature reviews. Cancer review Immunology and Microbiology Immunotherapy and Immune Responses cited by 15 patents

  1,576

  citations
• Preconditioning of the tumor microenvironment with oncolytic reovirus converts CD3-bispecific antibody treatment into effective immunotherapy

  2020 Journal for ImmunoTherapy of Cancer article Biochemistry, Genetics and Molecular Biology Virus-based gene therapy research Open access cited by 1 patent

  61

  citations
• Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions

  2020 Neuro-Oncology article Medicine Glioma Diagnosis and Treatment Open access cited by 1 patent

  1,195

  citations
• Immunotherapeutic Potential of TGF-β Inhibition and Oncolytic Viruses

  2020 Trends in Immunology review Medicine Cancer Immunotherapy and Biomarkers

  68

  citations

12 results